A pooled analysis of safety, efficacy of pembrolizumab in patients 75+ years of age with PD-L1+ NSCLC
A study showed patients seem to lack an understanding of the meaning of progression-free survival.
The neoantigens found in the patients’ tumors (non-small-cell lung cancer) which were highly dissimilar were enriched for hydrophobic sequences, and correlated with survival rates after the PD-1 checkpoint therapy.
Researchers examine patterns of recurrence after resection of pancreatic ductal adenocarcinoma.
Three scientists were awarded the Nobel Prize in Physiology of Medicine for their discovery of the mechanism of how cells regulate oxygen.
A multi-institutional pilot feasibility study looks at pencil beam scanning proton beam chemoradiation therapy with 5-fluorouracil
and mitomycin-C for definitive treatment of carcinoma of the anal canal.
A study found an association between treatment with ibrutinib and an increased risk for death from toxicities.
Following administration of checkpoint inhibitor therapy, 2.6% of patients experienced an acute vascular event within 6 months of starting treatment.
The study found patients with lung cancer referred to palliative care earlier lived longer.
The results of the TAILORx trial went against previous ideas that breast cancer patients with a high Oncotype score who needed chemotherapy and endocrine therapy wouldn't fare well.